144 related articles for article (PubMed ID: 35586055)
1. Corrigendum: Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes.
Arjmand B; Kokabi Hamidpour S; Alavi-Moghadam S; Yavari H; Shahbazbadr A; Rezaei-Tavirani M; Gilany K; Larijani B
Front Pharmacol; 2022; 13():892656. PubMed ID: 35586055
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum: Paraptosis: a unique cell death mode for targeting cancer.
Hanson S; Dharan A; V JP; Pal S; Nair BG; Kar R; Mishra N
Front Pharmacol; 2023; 14():1274076. PubMed ID: 37745056
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study.
Bhowmik R; Kant R; Manaithiya A; Saluja D; Vyas B; Nath R; Qureshi KA; Parkkila S; Aspatwar A
Front Pharmacol; 2023; 14():1340724. PubMed ID: 38264524
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
Saran U; Chandrasekaran B; Tyagi A; Shukla V; Singh A; Sharma AK; Damodaran C
Front Pharmacol; 2023; 14():1207589. PubMed ID: 37205914
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: Evaluation of Riboflavin Transporters as Targets for Drug Delivery and Theranostics.
Bartmann L; Schumacher D; von Stillfried S; Sternkopf M; Alampour-Rajabi S; van Zandvoort MAMJ; Kiessling F; Wu Z
Front Pharmacol; 2020; 11():617329. PubMed ID: 33324229
[TBL] [Abstract][Full Text] [Related]
6. Corrigendum: Targeting Myc Interacting Proteins as a Winding Path in Cancer Therapy.
Zhou Y; Gao X; Yuan M; Yang B; He Q; Cao J
Front Pharmacol; 2021; 12():785732. PubMed ID: 34744754
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis.
Liao M; Wang C; Yang B; Huang D; Zheng Y; Wang S; Wang X; Zhang J; Tang C; Xu Z; He Y; Huang R; Zhang F; Wang Z; Wang N
Front Pharmacol; 2022; 13():809565. PubMed ID: 35250560
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis.
Zheng F; Wang Y; Zhang Q; Chen Q; Liang CL; Liu H; Qiu F; Chen Y; Huang H; Lu W; Dai Z
Front Pharmacol; 2023; 14():1201715. PubMed ID: 37205909
[TBL] [Abstract][Full Text] [Related]
9. Corrigendum: COE Inhibits Vasculogenic Mimicry by Targeting EphA2 in Hepatocellular Carcinoma, a Research Based on Proteomics Analysis.
Chu Z; Shi X; Chen G; He X; Qian Y; Wang H; Tao L; Liu Y; Jiang W; Chen J
Front Pharmacol; 2021; 12():831941. PubMed ID: 35069227
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy.
Wang X; Yin G; Zhang W; Song K; Zhang L; Guo Z
Front Pharmacol; 2023; 14():1220144. PubMed ID: 37305537
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia.
Crocker CE; Tibbo PG
Front Pharmacol; 2018; 9():1417. PubMed ID: 30555331
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: Interactions Between
Qin Y; Wang S; Wen Q; Xia Q; Wang S; Chen G; Sun J; Shen C; Song S
Front Pharmacol; 2021; 12():831921. PubMed ID: 35069226
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Targeting Anion Exchange of Osteoclast, a New Strategy for Preventing Wear Particles Induced-Osteolysis.
Wu C; Liu X; Sun R; Qin Y; Liu Z; Yang S; Tang T; Zhu Z; Yu D; Liu F
Front Pharmacol; 2019; 10():1078. PubMed ID: 31588207
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells.
Wang X; Hui R; Chen Y; Wang W; Chen Y; Gong X; Jin J
Front Pharmacol; 2020; 11():603491. PubMed ID: 33381044
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Machine Learning Enables Accurate and Rapid Prediction of Active Molecules Against Breast Cancer Cells.
He S; Zhao D; Ling Y; Cai H; Cai Y; Zhang J; Wang L
Front Pharmacol; 2022; 13():901513. PubMed ID: 35707400
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: A Matrine Derivative M54 Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Targeting Ribosomal Protein S5.
Xin Z; Jin C; Chao L; Zheng Z; Liehu C; Panpan P; Weizong W; Xiao Z; Qingjie Z; Honggang H; Longjuan Q; Xiao C; Jiacan S
Front Pharmacol; 2021; 12():. PubMed ID: 33981210
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Nanostructured lipid carrier-mediated transdermal delivery of aceclofenac hydrogel present an effective therapeutic approach for inflammatory diseases.
Garg NK; Tandel N; Bhadada SK; Tyagi RK
Front Pharmacol; 2022; 13():1002649. PubMed ID: 36091766
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Inflammatory Stress Potentiates Emodin-Induced Liver Injury in Rats.
Tu C; Gao D; Li XF; Li CY; Li RS; Zhao YL; Li N; Jia GL; Pang JY; Cui HR; Ma ZJ; Xiao XH; Wang JB
Front Pharmacol; 2020; 11():597772. PubMed ID: 33568998
[TBL] [Abstract][Full Text] [Related]
19. Corrigendum: Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective.
Attah AF; Fagbemi AA; Olubiyi O; Dada-Adegbola H; Oluwadotun A; Elujoba A; Babalola CP
Front Pharmacol; 2021; 12():721060. PubMed ID: 34354598
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Danshensu methyl ester enhances autophagy to attenuate pulmonary fibrosis by targeting lncIAPF-HuR complex.
Zhu Q; Wang J; Ji Y; Luan J; Yue D; Liu W; Li H; Zhang J; Qu G; Lv C; Song X
Front Pharmacol; 2022; 13():1086927. PubMed ID: 36534046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
